genesignal.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Gene Signal : Biotechnology company discovering genes involved in the regulation of |
| Description | News Gene Signal is a research and development based biotechnology company focused on discovering genes involved in the regulation of angiogenesis. Gene Signal’s ophthalmic research program is pioneering targeted upstream blockade of pathological |
| Keywords | research and development, r&d, biotechnology, biotech, genes, angiogenesis, regulation, ophthalmic, ophthalmology, pathological angiogenesis, IRS-1 |
Server Information
| WebSite | |
| Host IP | 80.80.228.19 |
| Location | Switzerland |
Related Websites
| Site | Rank |
More to Explore
genesignal.com Valuation
|
US$263,621
Last updated: 2023-05-07 15:29:57
genesignal.com has Semrush global rank of 40,149,752. genesignal.com has an estimated worth of US$ 263,621, based on its estimated Ads revenue. genesignal.com receives approximately 30,418 unique visitors each day. Its web server is located in Switzerland, with IP address 80.80.228.19. According to SiteAdvisor, genesignal.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$263,621 |
| Daily Ads Revenue | US$244 |
| Monthly Ads Revenue | US$7,301 |
| Yearly Ads Revenue | US$87,604 |
| Daily Unique Visitors | 2,028 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| genesignal.com. | A | 3600 | IP: 80.80.228.19 |
| genesignal.com. | NS | 3600 | NS Record: ns1.mydomain.com. |
| genesignal.com. | NS | 3600 | NS Record: ns2.mydomain.com. |
| genesignal.com. | MX | 3600 | MX Record: 10 mx19-2.sherwebcloud.com. |
| genesignal.com. | MX | 3600 | MX Record: 10 mx19-1.sherwebcloud.com. |
| genesignal.com. | TXT | 3600 | TXT Record: v=spf1 ip4:173.46.152.128/25 -all |
HtmlToTextCheckTime:2023-05-07 15:29:57
| > print > contact us > site map > disclaimer --> --> Gene Signal is a research and development based biotechnology company focused on discovering genes involved in the regulation of angiogenesis. Gene Signal’s ophthalmic research program is pioneering targeted upstream blockade of pathological angiogenesis through the inhibition of Insulin Receptor Substrate 1 (IRS-1) “Topical Aganirsen produces a highly significant regression of corneal neovascularization” Cursiefen C., Ophthalmology. 2009 SEP;116(9):1630-7 “Topical application of Aganirsen offers a safe and effective therapy for both choroidal and retinal neovascularization without preventing its normal vascularization” Cloutier F. Invest Ophthalmol, Vis Sci. 2012 Mar 9 ; 53(3) :1195-203 News 05/05/2018 Gene Signal attends the Internal Congress of the Socit Franaise d’Ophtalmologie. more>> 03/05/2018 Gene Signal attends the Swiss Biotech Association Annual more>> 09/01/2017 Gene Signal attends JP Morgan |
HTTP Headers
HTTP/1.1 200 OK Content-Type: text/html; charset=iso-8859-1 Date: Thu, 28 Oct 2021 07:18:12 GMT Server: Apache/2.4.10 (Debian) Set-Cookie: fe_typo_user=4cca7aaba8a38f86c1d3661fc56fe6c6; path=/ Vary: Accept-Encoding |
genesignal.com Whois Information
Domain Name: GENESIGNAL.COM Registry Domain ID: 30738686_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.domain.com Registrar URL: http://www.domain.com Updated Date: 2021-06-17T12:56:15Z Creation Date: 2000-07-02T07:21:59Z Registry Expiry Date: 2022-07-02T07:21:58Z Registrar: Domain.com, LLC Registrar IANA ID: 886 Registrar Abuse Contact Email: compliance@domain-inc.net Registrar Abuse Contact Phone: 602-226-2389 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.MYDOMAIN.COM Name Server: NS2.MYDOMAIN.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-16T00:35:27Z <<< |